What is the recommended protocol for a computed tomography (CT) scan of the kidneys (renal protocol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Renal Protocol

For most clinical indications requiring renal CT imaging, perform IV contrast-enhanced CT of the abdomen and pelvis with immediate (nephrographic phase at 90-100 seconds) and delayed (excretory phase) images to comprehensively evaluate both renal parenchyma and the collecting system. 1

Standard Protocol Components

Contrast Administration

  • Use IV iodinated contrast material for optimal visualization of renal parenchyma, vasculature, and collecting system 1
  • Administer contrast at injection rates approximately equal to the flow rate in the vessel being evaluated 2
  • Maximum recommended total dose of iodine for adults is 80 grams 2
  • Hydrate patients before and after contrast administration 2

Imaging Phases

Nephrographic Phase (90-100 seconds post-contrast):

  • This is the most critical phase for detecting parenchymal abnormalities, including pyelonephritis, abscesses, and renal masses 3, 4
  • Accuracy of 90-92% for diagnosing acute pyelonephritis and complications 4
  • Provides optimal assessment of renal perfusion and parenchymal enhancement 3

Delayed/Excretory Phase (5-15 minutes post-contrast):

  • Essential for evaluating the collecting system, ureters, and bladder 1
  • Critical for detecting contrast extravasation from collecting system injuries in trauma 1
  • Necessary for identifying urothelial abnormalities and obstruction 1

Precontrast Phase:

  • Useful for detecting calculi (most sensitive modality for urinary stones) 1
  • Provides baseline attenuation values 1
  • Can be omitted if stone disease is not suspected and radiation dose reduction is prioritized 3

Indication-Specific Protocols

Renal Trauma

  • Perform triphasic CT (precontrast, nephrographic, and delayed phases) in stable patients with gross hematuria, microscopic hematuria with hypotension, or concerning mechanism of injury 1
  • Delayed images are mandatory to detect collecting system injuries and contrast extravasation 1
  • Include pelvis to evaluate for bladder injury, especially with pelvic fractures 1

Suspected Pyelonephritis or Renal Abscess

  • CT with IV contrast (nephrographic phase) is superior to all other modalities for detecting parenchymal changes and complications 3, 4
  • CT detects renal abscesses at 4.0% rate compared to 1.1% with ultrasound 4
  • Include pelvis to identify distal ureteral stones, congenital anomalies, or other sources 4
  • Imaging is NOT indicated for uncomplicated pyelonephritis unless patient fails to respond within 72 hours 3

Acute Kidney Injury (AKI)

  • Unenhanced CT is preferred to avoid contrast nephrotoxicity 1
  • Use CT primarily to characterize ultrasound-detected hydronephrosis and determine level/cause of obstruction 1
  • CT with IV contrast is NOT appropriate for diagnosing AKI 1
  • Most sensitive modality for detecting urinary calculi 1

Renovascular Disease

  • CTA with contrast-enhanced imaging when eGFR >30 mL/min/1.73 m² 1
  • For eGFR <30 mL/min/1.73 m², consider unenhanced MRA techniques or duplex Doppler ultrasound to avoid contrast nephrotoxicity 1
  • Recent evidence suggests low risk of contrast-induced nephropathy with stable eGFR >45 mL/min/1.73 m² 1

Critical Contraindications and Modifications

Renal Insufficiency

  • eGFR <30 mL/min/1.73 m²: Avoid iodinated contrast; use unenhanced CT or MRI alternatives 1
  • eGFR 30-45 mL/min/1.73 m²: Consider reduced iodine dose; risk-benefit assessment required 1
  • eGFR >45 mL/min/1.73 m²: Intravenous iodinated contrast is not an independent nephrotoxic risk factor 1
  • Iso-osmolar contrast (iodixanol) causes less SCr elevation than low-osmolar agents in high-risk patients 5

Pregnancy

  • Avoid CT whenever possible; use ultrasound or MRI as first-line 1
  • When CT is absolutely necessary, use low-dose protocol 1
  • Reserve for situations where diagnosis cannot be made on ultrasound or MRI 1

Pediatric Patients

  • Dose: 1-2 mL/kg for both intra-arterial and intravenous administration 2
  • Maximum dose should not exceed 2 mL/kg for CT or excretory urography 2
  • Maximum dose should not exceed 4 mL/kg for angiography 2

Common Pitfalls to Avoid

  • Never perform intrathecal administration of iodixanol—it is contraindicated and can cause death, seizures, and cerebral hemorrhage 2
  • Do not omit delayed phase imaging in trauma cases—up to 34% of renal injuries may be missed without excretory phase 1
  • Avoid extravasation, especially in patients with severe arterial or venous disease 2
  • Do not mix iodixanol with other drugs or inject in IV lines containing other medications 2
  • Do not rely solely on hematuria to determine need for imaging in trauma—mechanism of injury and physical findings are equally important 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Renal Ultrasound in Pyelonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Imaging Studies for Renal Abscesses due to Pyelonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.